Development of the Headache Activities of Daily Living Index: Initial Validity Study

Vernon, Howard; Lawson, Gordon E.

doi:10.1016/j.jmpt.2014.12.002

Cited by 18 publications

(13 citation statements)

References 34 publications

(43 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Forty-six articles provided evaluative evidence for 23 PROMs (Appendices 4 and 5 (Tables 3 and 4)). Six assessed impact of headaches overall: The EUROLIGHT ( 28 ); Headache Activities of Daily Living Index (HADLI) ( 29 ); Headache-specific Disability Questionnaire (HDQ) ( 30 ); the Headache Impact Test (HIT) ( 3 ) and its short-form HIT-6 ( 31 ); and a headache-specific modification of the Short-Form 36-item Health Survey ( 32 ). Five were specific to the impact of migraine: Functional Assessment in Migraine questionnaire (FAIM) ( 33 ); Headache Needs Assessment Survey (HANA) ( 34 ); MIgraine Disability ASessment (MIDAS) ( 35 ); Migraine-Specific Quality of Life Questionnaire (MSQ v2.1) ( 36 ); and the Migraine-Specific Quality of Life (MSQOL) measure ( 37 ).…”

Section: Resultsmentioning

confidence: 99%

Assessing the impact of headaches and the outcomes of treatment: A systematic review of patient-reported outcome measures (PROMs)

et al. 2017

View full text Add to dashboard Cite

AimsTo critically appraise, compare and synthesise the quality and acceptability of multi-item patient reported outcome measures for adults with chronic or episodic headache.MethodsSystematic literature searches of major databases (1980–2016) to identify published evidence of PROM measurement and practical properties. Data on study quality (COSMIN), measurement and practical properties per measure were extracted and assessed against accepted standards to inform an evidence synthesis.ResultsFrom 10,903 reviewed abstracts, 103 articles were assessed in full; 46 provided evidence for 23 PROMs: Eleven specific to the health-related impact of migraine (n = 5) or headache (n = 6); six assessed migraine-specific treatment response/satisfaction; six were generic measures. Evidence for measurement validity and score interpretation was strongest for two measures of impact, Migraine-Specific Quality of Life Questionnaire (MSQ v2.1) and Headache Impact Test 6-item (HIT-6), and one of treatment response, the Patient Perception of Migraine Questionnaire (PPMQ-R). Evidence of reliability was limited, but acceptable for the HIT-6. Responsiveness was rarely evaluated. Evidence for the remaining measures was limited. Patient involvement was limited and poorly reported.ConclusionWhile evidence is limited, three measures have acceptable evidence of reliability and validity: HIT-6, MSQ v2.1 and PPMQ-R. Only the HIT-6 has acceptable evidence supporting its completion by all “headache” populations.

show abstract

Section: Resultsmentioning

confidence: 99%

Assessing the impact of headaches and the outcomes of treatment: A systematic review of patient-reported outcome measures (PROMs)

et al. 2017

View full text Add to dashboard Cite

show abstract

“…26 Additional PROMs located in the course of the literature search were also reviewed, again focusing on content validation information. These PROMs included Headache Activities of Daily Living Index, 27 Completeness of Response Survey, 28 Impact of Migraine on Partners and Adolescent Children scale, 29 Functional Assessment in Migraine questionnaire, 30 Migraine-Specific QoL instrument, 31 Patient Perceptions of Migraine questionnaire 32 (and its revised version 33 ), and 24-hour Migraine QoL Questionnaire. 34 The basic search function of the National Library of Medicine, via PubMed (with minimal use of filters or specific field identifiers), was used (eg, "headache impact test" [All Fields]).…”

Section: Methodsmentioning

confidence: 99%

Content Validity of HIT‐6 as a Measure of Headache Impact in People With Migraine: A Narrative Review

et al. 2019

View full text Add to dashboard Cite

Background.-The short-form Headache Impact Test (HIT-6) is a widely used patient-reported outcome measure that assesses the negative effects of headaches on normal activity. It was developed using the general headache population and prior to the establishment of the now well-accepted FDA patient-reported guidance. Objective.-The objective of this narrative review was to examine existing qualitative research in patients with migraine and headache, providing insight into the relevance and meaningfulness of HIT-6 items to the lives of migraine patients. Methods.-Articles were identified through database searches (National Library of Medicine and Google Scholar) and review of reference lists of candidate articles. Results.-A total of 3227 articles were identified through database and hand searching. Of these, 12 contained patient-or expert-generated qualitative information regarding headache patients' experience (8 specific to migraine [episodic and chronic] patients and 4 citing general headache patients). The combined publications described a total of 283 patient interviews. Overarching themes and specific information were identified that provide support of the relevance of content for each HIT-6 item to migraine patients' lives. Identified effects of headaches on patients with migraine included limitations in daily activities, needing to lie down during headaches, feeling tired, being irritated by headaches, difficulty concentrating, and the experience of pain. Further, previous research specific to the HIT-6 indicated that patients understood the instructions, items, and response scales as intended by the instrument authors. Conclusions.-This narrative literature review demonstrates qualitative research support for the relevance of the items of the HIT-6 in migraine patients, supporting its ongoing use in clinical migraine research and practice.

show abstract

“…Reliability for measuring PPT was reported as excellent (ICC: 0.82-0.99) [49]. Headache disability will be recorded with the Headache Activities of Daily Living Index (HADLI) [50] which is a 9 item self-reported questionnaire designed to measure the impact of headache on quality of life. Each item has 6 sub-questions which are rated from 0 to 5 thus the maximum score of 45 indicates a severe disability.…”

Section: Discussionmentioning

confidence: 99%

Effectiveness of Mulligan manual therapy over exercise on headache frequency, intensity and disability for patients with migraine, tension-type headache and cervicogenic headache – a protocol of a pragmatic randomized controlled trial

Satpute

Bedekar

Hall

2021

BMC Musculoskelet Disord

View full text Add to dashboard Cite

Background Non - pharmacological management of migraine, tension-type headache (TTH), and cervicogenic headache (CGH) may include spinal manual therapy and exercise. Mulligan Manual Therapy (MMT) utilizes a protocol of headache elimination procedures to manage headache parameters and associated disability, but has only been evaluated in CGH. There is little evidence for its effectiveness in migraine and TTH. This study aims to determine the effectiveness of MMT and exercise over exercise and placebo in the management of migraine, TTH, and CGH. Methods This pragmatic trial is designed as a prospective, three-armed randomised controlled trial in a clinical setting provided at a general hospital physiotherapy department. Two hundred ninety-seven participants with a diagnosis of migraine, TTH or CGH based on published headache classification guidelines will be included. An assessor blind to group allocation will measure outcomes pre-and post-intervention as well as 3 and 6 months after commencement of treatment. Participants will be allocated to one of the three groups: MMT and exercise; placebo and exercise; and exercise alone. The primary outcome measure is headache frequency. Secondary outcome measures are headache duration and intensity, medication intake, pressure pain threshold (PPT), range of motion recorded with the flexion rotation test, and headache disability recorded with Headache Activities of Daily Living Index (HADLI). The intention-to-treat principle will be followed for statistical analysis. Between groups differences for all outcome measures at baseline and at reassessment points and 95% confidence intervals will be calculated using a mixed model ANOVA. Post hoc tests will be conducted to identify any significant difference between groups and over time. Discussion This pragmatic study will provide evidence for the effectiveness of MMT when compared with a placebo intervention and exercise on headache frequency, intensity, and disability. Limitations are that baseline evaluation of headache parameters may be affected by recall bias. External validity will be limited to the population with a minimum 1-year history of headache. The HADLI is not yet extensively evaluated for its psychometric properties and association between PPT and headache parameters is lacking. Performance bias is inevitable as a single therapist will be delivering all interventions. Trial registration The trial was registered prospectively under the Clinical Trial Registry India (Registration number: CTRI/2019/06/019506, dated on 03/06/2019). .

show abstract

Development of the Headache Activities of Daily Living Index: Initial Validity Study

Abstract: The HADLI was created using theory and empirical-based methods. Face validity was assessed by focus group input and by first-level psychometrics. The HADLI has good face validity and is suitable for further reliability and validity testing.

Cited by 18 publications

References 34 publications

Assessing the impact of headaches and the outcomes of treatment: A systematic review of patient-reported outcome measures (PROMs)

Assessing the impact of headaches and the outcomes of treatment: A systematic review of patient-reported outcome measures (PROMs)

Content Validity of HIT‐6 as a Measure of Headache Impact in People With Migraine: A Narrative Review

Effectiveness of Mulligan manual therapy over exercise on headache frequency, intensity and disability for patients with migraine, tension-type headache and cervicogenic headache – a protocol of a pragmatic randomized controlled trial

Contact Info

Product

Resources

About